Insulet Corp
PODD: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|?t | LOCK|xN#># | LOCK|r!Z<^>t& |
Insulet Earnings: Strong Start to 2026, but Higher Guidance May Have Disappointed
Insulet reported first-quarter results that featured constant-currency revenue growth of 30% and adjusted earnings growth of 29%. Management raised its outlook for 2026 revenue growth and operating margin by 100 basis points at the midpoint.
